Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

352 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911).
Bolla M, van Poppel H, Collette L, van Cangh P, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Maréchal JM, Scalliet P, Haustermans K, Piérart M; European Organization for Research and Treatment of Cancer. Bolla M, et al. Among authors: haustermans k. Lancet. 2005 Aug 13-19;366(9485):572-8. doi: 10.1016/S0140-6736(05)67101-2. Lancet. 2005. PMID: 16099293 Clinical Trial.
Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer.
Machiels JP, Sempoux C, Scalliet P, Coche JC, Humblet Y, Van Cutsem E, Kerger J, Canon JL, Peeters M, Aydin S, Laurent S, Kartheuser A, Coster B, Roels S, Daisne JF, Honhon B, Duck L, Kirkove C, Bonny MA, Haustermans K. Machiels JP, et al. Among authors: haustermans k. Ann Oncol. 2007 Apr;18(4):738-44. doi: 10.1093/annonc/mdl460. Epub 2007 Jan 5. Ann Oncol. 2007. PMID: 17208931 Free article. Clinical Trial.
Molecular response to cetuximab and efficacy of preoperative cetuximab-based chemoradiation in rectal cancer.
Debucquoy A, Haustermans K, Daemen A, Aydin S, Libbrecht L, Gevaert O, De Moor B, Tejpar S, McBride WH, Penninckx F, Scalliet P, Stroh C, Vlassak S, Sempoux C, Machiels JP. Debucquoy A, et al. Among authors: haustermans k. J Clin Oncol. 2009 Jun 10;27(17):2751-7. doi: 10.1200/JCO.2008.18.5033. Epub 2009 Mar 30. J Clin Oncol. 2009. PMID: 19332731 Clinical Trial.
A multi-institutional analysis comparing adjuvant and salvage radiation therapy for high-risk prostate cancer patients with undetectable PSA after prostatectomy.
Budiharto T, Perneel C, Haustermans K, Junius S, Tombal B, Scalliet P, Renard L, Lerut E, Vekemans K, Joniau S, Van Poppel H. Budiharto T, et al. Among authors: haustermans k. Radiother Oncol. 2010 Dec;97(3):474-9. doi: 10.1016/j.radonc.2010.07.008. Epub 2010 Oct 13. Radiother Oncol. 2010. PMID: 20950879
Quality of care indicators in rectal cancer.
Demetter P, Ceelen W, Danse E, Haustermans K, Jouret-Mourin A, Kartheuser A, Laurent S, Mollet G, Nagy N, Scalliet P, Van Cutsem E, Van Den Eynde M, Van de Stadt J, Van Eycken E, Van Laethem JL, Vindevoghel K, Penninckx F. Demetter P, et al. Among authors: haustermans k. Acta Gastroenterol Belg. 2011 Sep;74(3):445-50. Acta Gastroenterol Belg. 2011. PMID: 22103052 Free article. Review.
Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911).
Bolla M, van Poppel H, Tombal B, Vekemans K, Da Pozzo L, de Reijke TM, Verbaeys A, Bosset JF, van Velthoven R, Colombel M, van de Beek C, Verhagen P, van den Bergh A, Sternberg C, Gasser T, van Tienhoven G, Scalliet P, Haustermans K, Collette L; European Organisation for Research and Treatment of Cancer, Radiation Oncology and Genito-Urinary Groups. Bolla M, et al. Among authors: haustermans k. Lancet. 2012 Dec 8;380(9858):2018-27. doi: 10.1016/S0140-6736(12)61253-7. Epub 2012 Oct 19. Lancet. 2012. PMID: 23084481 Clinical Trial.
352 results